ARWR Cash-Secured Put Strategy
ARWR (Arrowhead Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States. The company's extensive therapeutic pipeline primarily leverages RNA interference (RNAi) technology. Among its advanced clinical programs are: ARO-AAT, a Phase II therapeutic targeting liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is undergoing both Phase 2b and Phase 3 clinical evaluations for hypertriglyceridemia; ARO-ANG3, currently in Phase 2b development to reduce the production of angiopoietin-like protein 3; and ARO-HIF2, a Phase 1b candidate designed to treat clear cell renal cell carcinoma. Arrowhead also has several compounds in earlier clinical development, including ARO-HSD in Phase 1/2a for other liver diseases, ARO-ENaC in Phase 1/2a, aimed at decreasing the epithelial sodium channel alpha subunit in lung airways, and ARO-C3, also in Phase 1/2a, for complement-mediated diseases. Further expanding its diverse portfolio, the company is actively developing ARO-Lung2 for chronic obstructive pulmonary disorder (COPD), ARO-DUX4 for facioscapulohumeral muscular dystrophy, ARO-XDH for uncontrolled gout, and ARO-COV for COVID-19 and other pulmonary-borne pathogens. Beyond its core internal programs, Arrowhead is involved in the progression of JNJ-3989, a subcutaneously administered RNAi therapeutic for chronic hepatitis B virus infection; Olpasiran, intended to reduce apolipoprotein A production; and ARO-AMG1, which targets genetically validated cardiovascular pathways.
ARWR (Arrowhead Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $11.11B, a beta of 1.28 versus the broader market, a 52-week range of 14.3-84.549, average daily share volume of 2.0M, a public-listing history dating back to 1993, approximately 609 full-time employees. These structural characteristics shape how ARWR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.28 places ARWR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a cash-secured put on ARWR?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
Current ARWR snapshot
As of June 30, 2026, spot at $82.74, ATM IV 57.60%, IV rank 25.22%, expected move 16.51%. The cash-secured put on ARWR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this cash-secured put structure on ARWR specifically: ARWR IV at 57.60% is on the cheap side of its 1-year range, which means a premium-selling ARWR cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 16.51% (roughly $13.66 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ARWR expiries trade a higher absolute premium for lower per-day decay. Position sizing on ARWR should anchor to the underlying notional of $82.74 per share and to the trader's directional view on ARWR stock.
ARWR cash-secured put setup
The ARWR cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ARWR near $82.74, the first option leg uses a $77.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ARWR chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ARWR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $77.50 | $2.33 |
ARWR cash-secured put risk and reward
- Net Premium / Debit
- +$232.50
- Max Profit (per contract)
- $232.50
- Max Loss (per contract)
- -$7,516.50
- Breakeven(s)
- $75.18
- Risk / Reward Ratio
- 0.031
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
ARWR cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on ARWR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$7,516.50 |
| $18.30 | -77.9% | -$5,687.18 |
| $36.60 | -55.8% | -$3,857.87 |
| $54.89 | -33.7% | -$2,028.55 |
| $73.18 | -11.6% | -$199.23 |
| $91.48 | +10.6% | +$232.50 |
| $109.77 | +32.7% | +$232.50 |
| $128.06 | +54.8% | +$232.50 |
| $146.36 | +76.9% | +$232.50 |
| $164.65 | +99.0% | +$232.50 |
When traders use cash-secured put on ARWR
Cash-secured puts on ARWR earn premium while a trader waits to acquire ARWR stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning ARWR.
ARWR thesis for this cash-secured put
The market-implied 1-standard-deviation range for ARWR extends from approximately $69.08 on the downside to $96.40 on the upside. A ARWR cash-secured put lets a trader earn premium while waiting to acquire ARWR at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current ARWR IV rank near 25.22% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ARWR at 57.60%. As a Healthcare name, ARWR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ARWR-specific events.
ARWR cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ARWR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ARWR alongside the broader basket even when ARWR-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on ARWR carry tail risk when realized volatility exceeds the implied move; review historical ARWR earnings reactions and macro stress periods before sizing. Always rebuild the position from current ARWR chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on ARWR?
- A cash-secured put on ARWR is the cash-secured put strategy applied to ARWR (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With ARWR stock trading near $82.74, the strikes shown on this page are snapped to the nearest listed ARWR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ARWR cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the ARWR cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 57.60%), the computed maximum profit is $232.50 per contract and the computed maximum loss is -$7,516.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ARWR cash-secured put?
- The breakeven for the ARWR cash-secured put priced on this page is roughly $75.18 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ARWR market-implied 1-standard-deviation expected move is approximately 16.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on ARWR?
- Cash-secured puts on ARWR earn premium while a trader waits to acquire ARWR stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning ARWR.
- How does current ARWR implied volatility affect this cash-secured put?
- ARWR ATM IV is at 57.60% with IV rank near 25.22%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.